Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Fc fragment (crystallizable fragment) of immunoglobulin G (IgG) is the constant region of the antibody that interacts with cell surface receptors and complement proteins, mediating immune effector functions. When tumor-targeting monoclonal antibodies (mAbs) bind to their specific antigens on cancer cells, their Fc regions become accessible for interactions with various immune components. The Fc region plays a critical role in recruiting innate immunity to eliminate tumor cells.
Recruitment of immune effectors via binding to Fc receptors (FcγRs), complement protein C1q, and neonatal Fc receptor (FcRn).
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fc Fragment of IgG (Fc).